Sale

Fertility Supplements Market

Global Fertility Supplements Market Size, Share, Trends, Growth: By Ingredient Type: Natural, Synthetic/Blend of Natural & Synthetic; By Product Type: Capsules, Tablets, Soft gels, Powders, Liquids; By Procedure: IVF with ICSI, IUI, Surrogacy, Others; By End User; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Fertility Supplements Market Outlook

The global fertility supplements market value in 2023 was USD 2.09 billion driven by the increasing awareness about fertility issues, rising infertility rates across the globe. The market size is anticipated to grow at a CAGR of 8.3% during the forecast period of 2024-2032 to achieve a value of USD 4.28 billion by 2032.

 

Global Fertility Supplements Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The industry is being supported by the declining fertility rates owing to the changes in lifestyle, including the rising consumption of cigarettes and alcohol. The increasing geriatric population, healthcare costs, and medical discoveries have helped in the growth of the overall fertility supplements industry.

 

Market Segmentation

The global fertility supplements market can be divided based on segments like products, ingredients, distributional channels, and end-uses.

 

Global Fertility Supplements Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on its products, the industry is segmented into:

  • Capsules
  • Tablets
  • Soft Gels
  • Powder
  • Liquids

Based on ingredients, the industry is categorised as natural ingredients and synthetic/blend of synthetic and natural ingredients. Based on distributional channels, the industry is categorised as OTC and prescribed. Based on its end-use segments, the industry is bifurcated into men and women.

The EMR report looks into the regional fertility supplements markets like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

 

Market Analysis

The growing adoption of herbal medicines (botanicals) due to the increasing concerns about the harmful impacts associated with the traditional pharmaceutical drugs is expected to generate new opportunities for the fertility supplements manufacturers, leading to the growth of the fertility supplements industry. Various public initiatives to raise awareness regarding advancements in fertility supplements among consumers and its superior technology have helped the industry gain a further boost. On the other hand, the increasing significance of food products such as avocados, olive oil, whole grains, and high-fat dairy products to increase fertility is anticipated to aid the functional foods and drinks sector, which may hinder the growth of the global fertility supplements industry over the forecast period.

 

Global Fertility Supplements Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global fertility supplements market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Fairhaven Health 
  • Coast Science 
  • Lenus Pharma GesmbH 
  • Active Bio Life Science GmbH 
  • Orthomol 
  • Exeltis USA, Inc. 
  • PregPrep LLC 
  • Bionova 
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Ingredient Type
  • Product Type
  • Procedure
  • End User
  • Distribution Channel
  • Region
Breakup by Ingredient Type
  • Natural
  • Synthetic/Blend of Natural & Synthetic
Breakup by Product Type
  • Capsules
  • Tablets
  • Soft gels
  • Powders
  • Liquids
Breakup by Procedure
  • IVF with ICSI
  • IUI
  • Surrogacy
  • IVF without ICSI
  • Others
Breakup by End User
  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes
  • Others
Breakup by Distribution Channel
  • Over The Counter (OTC)
  • Prescribed
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • CARE Fertility
  • Xytex Corporation
  • FUJIFILM Irvine Scientific
  • INVO Bioscience
  • ALABAMA FERTILITY
  • Shivani Scientific
  • IVFtech Aps
  • WebMD LLC
  • Coast Science
  • Ocean Healthcare Private Limited
  • Genea Limited
  • Medicover AB
  • Monash IVF Australia
  • Progyny, Inc
  • Apollo Fertility
  • Carolinas Fertility Institute
  • Bayer AG
  • Zenith Nutrition
  • SUPPLEMENA
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Fertility Supplements Market Overview
 
    3.1    Global Fertility Supplements Market Historical Value (2017-2023) 
    3.2    Global Fertility Supplements Market Forecast Value (2024-2032)
4    Global Fertility Supplements Market Landscape
    4.1    Global Fertility Supplements Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Fertility Supplements Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Technology
        4.2.3    Analysis by End User
5    Global Fertility Supplements Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Fertility Supplements Market Segmentation
    6.1    Global Fertility Supplements Market by Ingredient Type
        6.1.1    Market Overview
        6.1.2    Natural 
        6.1.3    Synthetic/Blend of Natural & Synthetic
    6.2    Global Fertility Supplements Market by Product Type
        6.2.1    Market Overview
        6.2.2    Capsules
        6.2.3    Tablets
        6.2.4    Soft gels
        6.2.5    Powders
        6.2.6    Liquids
    6.3    Global Fertility Supplements Market by Procedure
        6.3.1    Market Overview
        6.3.2    IVF with ICSI
        6.3.3    IUI
        6.3.4    Surrogacy
        6.3.5    IVF without ICSI
        6.3.6    Others
    6.4    Global Fertility Supplements Market by End User
        6.4.1    Market Overview
        6.4.2    Fertility Clinics
        6.4.3    Hospitals
        6.4.4    Surgical Centers
        6.4.5    Clinical Research Institutes
        6.4.6    Others
    6.5    Global Fertility Supplements Market by Distribution Channel
        6.5.1    Market Overview
        6.5.2    Over The Counter (OTC)
        6.5.3    Prescribed
    6.6    Global Fertility Supplements Market by Region
        6.6.1    Market Overview
        6.6.2    North America 
        6.6.3    Europe
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Fertility Supplements Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Fertility Supplements Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Fertility Supplements Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Fertility Supplements Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Fertility Supplements Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Clinical Trials Analysis
    14.1     Analysis by Trial Registration Year 
    14.2    Analysis by Trial Status 
    14.3    Analysis by Trial Phase 
    14.4    Analysis by Therapeutic Area 
    14.5    Analysis by Geography 
15    Funding Analysis
    15.1    Analysis by Funding Instances
    15.2    Analysis by Type of Funding
    15.3    Analysis by Funding Amount
    15.4    Analysis by Leading Players
    15.5    Analysis by Leading Investors
    15.6    Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1    Analysis by Partnership Instances
    16.2    Analysis by Type of Partnership
    16.3    Analysis by Leading Players
    16.4    Analysis by Geography
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Supplier Landscape
    18.1    CARE Fertility
        18.1.1    Financial Analysis
        18.1.2    Product Portfolio
        18.1.3    Demographic Reach and Achievements
        18.1.4    Mergers and Acquisitions
        18.1.5    Certifications
    18.2    Xytex Corporation
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisitions
        18.2.5    Certifications
    18.3    FUJIFILM Irvine Scientific
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisitions
        18.3.5    Certifications
    18.4    INVO Bioscience
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisitions
        18.4.5    Certifications
    18.5    ALABAMA FERTILITY
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisitions
        18.5.5    Certifications
    18.6    Shivani Scientific
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisitions
        18.6.5    Certifications
    18.7    IVFtech Aps
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisitions
        18.7.5    Certifications
    18.8    WebMD LLC
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisitions
        18.8.5    Certifications
    18.9    Coast Science
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Mergers and Acquisitions
        18.9.5    Certifications
    18.10    Ocean Healthcare Private Limited
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Mergers and Acquisitions
        18.10.5    Certifications
    18.11    Genea Limited
        18.11.1    Financial Analysis
        18.11.2    Product Portfolio
        18.11.3    Demographic Reach and Achievements
        18.11.4    Mergers and Acquisitions
        18.11.5    Certifications
    18.12    Medicover AB
        18.12.1    Financial Analysis
        18.12.2    Product Portfolio
        18.12.3    Demographic Reach and Achievements
        18.12.4    Mergers and Acquisitions
        18.12.5    Certifications
    18.13    Monash IVF Australia
        18.13.1    Financial Analysis
        18.13.2    Product Portfolio
        18.13.3    Demographic Reach and Achievements
        18.13.4    Mergers and Acquisitions
        18.13.5    Certifications
    18.14    Progyny, Inc
        18.14.1    Financial Analysis
        18.14.2    Product Portfolio
        18.14.3    Demographic Reach and Achievements
        18.14.4    Mergers and Acquisitions
        18.14.5    Certifications
    18.15    Apollo Fertility
        18.15.1    Financial Analysis
        18.15.2    Product Portfolio
        18.15.3    Demographic Reach and Achievements
        18.15.4    Mergers and Acquisitions
        18.15.5    Certifications
    18.16    Carolinas Fertility Institute
        18.16.1    Financial Analysis
        18.16.2    Product Portfolio
        18.16.3    Demographic Reach and Achievements
        18.16.4    Mergers and Acquisitions
        18.16.5    Certifications
    18.17    Bayer AG
        18.17.1    Financial Analysis
        18.17.2    Product Portfolio
        18.17.3    Demographic Reach and Achievements
        18.17.4    Mergers and Acquisitions
        18.17.5    Certifications
    18.18    Zenith Nutrition
        18.18.1    Financial Analysis
        18.18.2    Product Portfolio
        18.18.3    Demographic Reach and Achievements
        18.18.4    Mergers and Acquisitions
        18.18.5    Certifications
    18.19    SUPPLEMENA
        18.19.1    Financial Analysis
        18.19.2    Product Portfolio
        18.19.3    Demographic Reach and Achievements
        18.19.4    Mergers and Acquisitions
        18.19.5    Certifications
19    Global Fertility Supplements Market - Distribution Model (Additional Insight)
    19.1    Overview 
    19.2    Potential Distributors 
    19.3    Key Parameters for Distribution Partner Assessment 
20    Key Opinion Leaders (KOL) Insights (Additional Insight)
21    Company Competitiveness Analysis (Additional Insight)

    21.1    Very Small Companies
    21.2    Small Companies
    21.3    Mid-Sized Companies
    21.4    Large Companies
    21.5    Very Large Companies
22    Payment Methods (Additional Insight)
    22.1    Government Funded
    22.2    Private Insurance
    22.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

It is estimated that the global market for fertility supplements reached a value of USD 2.09 billion in 2023.

The market is forecasted to grow at a CAGR 8.3% during the forecast period of 2024-2032 to reach a value of USD 4.28 billion by 2032.

The industry is being aided by changes in lifestyle such as smoking, increased alcohol consumption, dropping fertility rates, growing senior population, and rising healthcare expenditures.

Key trends like the acceptance of herbal medicines (botanicals) and various public campaigns to enhance consumer knowledge are expected to boost the market.

The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

The major products in the industry are capsules, tablets, soft gels, powder, and liquids.

Based on ingredients, the industry is categorised as natural ingredients and synthetic/blend of synthetic and natural ingredients.

The leading distribution channels in the market are OTC and prescribed.

The various end uses of the product are men and women.

The major players in the industry are Fairhaven Health, Coast Science, LLC, LENUS Pharma GesmbH, Active Bio Life Science GmbH, Orthomol pharmazeutische Vertriebs GmbH, Exeltis USA, Inc., and Bionova Lifesciences, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER